AstraZeneca Plc Is Tougher Pfizer Inc. Target as Possible Bid Looms

Pfizer Inc. Celebrex brand heartburn medication sits on a shelf at a pharmacy in Princeton, Illinois, U.S., on Wednesday, Aug. 20, 2014. Pfizer Inc. isnt giving up on striking an overseas takeover to cut its tax rate and gain a new pipeline of drugs, even as the potential cost of acquiring AstraZeneca Plc rises. Photographer: Daniel Acker/Bloomberg via Getty Images
Pfizer Inc. Celebrex brand heartburn medication sits on a shelf at a pharmacy in Princeton, Illinois, U.S., on Wednesday, Aug. 20, 2014. Pfizer Inc. isnt giving up on striking an overseas takeover to cut its tax rate and gain a new pipeline of drugs, even as the potential cost of acquiring AstraZeneca Plc rises. Photographer: Daniel Acker/Bloomberg via Getty Images
AstraZeneca Plc Is Tougher Pfizer Inc. Target as Possible Bid Looms
KÖP EN LICENS
Hur får jag använda den här bilden?
kr 4,200.00
SEK

INFORMATION

Begränsningar:
Kontakta ditt lokala kontor för all kommersiell eller marknadsföringsrelaterad användning.For editorial use only. Additional clearance required for commercial or promotional use, contact your local office for assistance. Any commercial or promotional use of Bloomberg content requires Bloomberg's prior written consent.
Upphovsman:
Bloomberg / Contributor
Redaktionell fil nr:
453912480
Samling:
Bloomberg
Datum skapat:
20 augusti 2014
Uppladdningsdatum:
Licenstyp:
Rättighetsskyddat
Releaseinformation:
Saknar release. Mer information
Källa:
Bloomberg
Objektnamn:
ASTRAZENECA PFIZER